Chargement en cours...

Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome

Fibroblast growth factor-21 (FGF21) is elevated in patients with the metabolic syndrome. Although the exact underlying mechanisms remain ill-defined, chronic low-grade inflammation with increased Interleukin-(IL)-1β expression may be responsible. The aim of this study was to investigate effects of t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Sci Rep
Auteurs principaux: Ebrahimi, Fahim, Urwyler, Sandrine Andrea, Betz, Matthias Johannes, Christ, Emanuel Remigius, Schuetz, Philipp, Mueller, Beat, Donath, Marc Yves, Christ-Crain, Mirjam
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2021
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8041761/
https://ncbi.nlm.nih.gov/pubmed/33846498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-87207-w
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!